[Novel intermittent GnRHa therapy for patients with endometriosis].

Tanaka T, Tomoaki Tanaka, T Tanaka, Naohiko Umesaki, N Umesaki, Umesaki N
Nihon rinsho. Japanese journal of clinical medicine · 2001 · vol. 59 Suppl 1 , pp. 124–8 · PMID:11235149 · W2410415168
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper describes a novel intermittent gonadotropin-releasing hormone agonist (GnRHa) therapy approach for managing endometriosis in patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Gonadotropin-Releasing Hormone Delayed-Action Preparations Drug Administration Schedule Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Injections, Subcutaneous Leuprolide Leuprolide Leuprolide Middle Aged

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-05T06:14:40.014199+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:30.513821+00:00
License: CC0 · commercial use OK